<?xml-stylesheet type='text/xsl' href='ctgovTransform.xsl'?>
<CT.GOV_Trial requestNumber="5721">
  <stage>Registered</stage>
  <submitdate>8/02/2015</submitdate>
  <approvaldate>8/02/2015</approvaldate>
  <nctid>NCT02368639</nctid>
  <trial_identification>
    <studytitle>Feasibility of a Modified Positive Airway Pressure Device to Treat Sleep Disordered Breathing</studytitle>
    <scientifictitle>Feasibility of a Modified Positive Airway Pressure Device to Treat Sleep Disordered Breathing</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>CIA-156</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Sleep Apnea, Obstructive</healthcondition>
    <healthcondition>Obesity Hypoventilation Syndrome</healthcondition>
    <conditioncode>
      <conditioncode1>Respiratory</conditioncode1>
      <conditioncode2>Sleep apnoea</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Respiratory</conditioncode1>
      <conditioncode2>Other respiratory disorders / diseases</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Diet and Nutrition</conditioncode1>
      <conditioncode2>Obesity</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Treatment: devices - Fisher &amp; Paykel Healthcare PAP Device

Experimental: Positive airway pressure (PAP) device - Fisher &amp; Paykel Healthcare PAP Device. Participants will sleep overnight using themodified positive airway pressure device. Their pressures will be titrated by a qualified sleep technician, they will then be optimised during the night.


Treatment: devices: Fisher &amp; Paykel Healthcare PAP Device
The device is a modified version of the Fisher &amp; Paykel Icon continuous positive airway pressure (CPAP) device, which is a fully released product in New Zealand.

</interventions>
    <comparator />
    <control />
    <interventioncode>Treatment: devices</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Apnea hypopnea index (AHI) - The number of apnea and hypopneas will be measured</outcome>
      <timepoint>8 hours</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Peripheral blood oxygen level (SpO2) - Peripheral blood oxygen level will be measured</outcome>
      <timepoint>8 hours</timepoint>
    </primaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>-  Aged 18+

          -  Patients diagnosed with obesity hypoventilation syndrome (OHS) and/or obstructive
             sleep apnea (OSA) by a practicing sleep or respiratory physician, requiring positive
             airway pressure (PAP) therapy</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage />
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>-  Recent cardiac or respiratory arrest

          -  Gastro intestinal bleeding, ileus or recent gastrointestinal surgery

          -  Coma, decreased level of consciousness or agitation

          -  Anatomical or subjective difficulty with airway access e.g. facial surgery, trauma,
             vomiting upper airway obstruction

          -  Cerebrospinal fluid leak, abnormalities of the cribiform plate or prior history of
             head trauma.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation />
    <concealment />
    <sequence />
    <masking>Blinded (masking used)</masking>
    <assignment>Single group</assignment>
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate />
    <actualstartdate>1/01/2015</actualstartdate>
    <anticipatedenddate />
    <actualenddate />
    <samplesize />
    <actualsamplesize>14</actualsamplesize>
    <recruitmentstatus>Terminated</recruitmentstatus>
    <anticipatedlastvisitdate />
    <actuallastvisitdate>1/03/2016</actuallastvisitdate>
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry />
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>New Zealand</country>
      <state>Auckland</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Commercial sector/Commercial sector/Industry</primarysponsortype>
    <primarysponsorname>Fisher and Paykel Healthcare</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry />
  </sponsorship>
  <ethicsAndSummary>
    <summary>This study will use a modified version of a positive airway pressure device to supply air to
      the participant, while undergoing supervised polysomnography. Positive airway pressures are
      typically applied to many patients with hypoventilation, in this study these pressures will
      be titrated by a qualified sleep technician. During the night these pressures will be altered
      to optimise comfort.</summary>
    <trialwebsite>https://clinicaltrials.gov/show/NCT02368639</trialwebsite>
    <publication />
    <ethicsreview />
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Public Queries</type>
    </contact>
  </contacts>
</CT.GOV_Trial>